Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years

por Baraliakos, X, Brandt, J, Listing, J, Sieper, J, Braun, J
Publicado 2005

Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

por Baraliakos, X, Listing, J, Brandt, J, Rudwaleit, M, Sieper, J, Braun, J
Publicado 2005

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab

por Baraliakos, X, Listing, J, Rudwaleit, M, Brandt, J, Sieper, J, Braun, J
Publicado 2005

Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis

por Baraliakos, X, Brandt, J, Listing, J, Haibel, H, Rudwaleit, HM, Sieper, J, Braun, J
Publicado 2005

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual pa...

por Strangfeld, A, Eveslage, M, Schneider, M, Bergerhausen, H J, Klopsch, T, Zink, A, Listing, J
Publicado 2011

Evaluation of the RABBIT Risk Score for serious infections

por Zink, A, Manger, B, Kaufmann, J, Eisterhues, C, Krause, A, Listing, J, Strangfeld, A
Publicado 2014

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

por Richter, A, Listing, J, Schneider, M, Klopsch, T, Kapelle, A, Kaufmann, J, Zink, A, Strangfeld, A
Publicado 2016

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort

por Meissner, Y, Richter, A, Manger, B, Tony, HP, Wilden, E, Listing, J, Zink, A, Strangfeld, A
Publicado 2017

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARD...

por Strangfeld, A, Richter, A, Siegmund, B, Herzer, P, Rockwitz, K, Demary, W, Aringer, M, Meißner, Y, Zink, A, Listing, J
Publicado 2017

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: resul...

por Song, I-H, Hermann, K G, Haibel, H, Althoff, C E, Poddubnyy, D, Listing, J, Weiß, A, Freundlich, B, Rudwaleit, M, Sieper, J
Publicado 2011

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled t...

por Song, I-H, Hermann, KG, Haibel, H, Althoff, CE, Listing, J, Burmester, GR, Krause, A, Bohl-Bühler, M, Freundlich, B, Rudwaleit, M, Sieper, J
Publicado 2011